Speaking at the India-New Zealand Economic Forum, New Zealand Prime Minister Christopher Luxon expressed confidence in the trade ministers’ ability to fast-track the agreement.

Company expects to have sufficient cash to fund planned operations beyond the FDA PDUFA goal date and anticipated fourth quarter 2025 launch of TNX-102 SL for fibromyalgia; $98.8 million in cash as of ...